Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ESTRAMUSTINE for Hormone-refractory prostate cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where ESTRAMUSTINE was used for Hormone-refractory prostate cancer.

Most Reported Side Effects for ESTRAMUSTINE

Side Effect Reports % Deaths Hosp.
Nausea 17 6.3% 3 7
Interstitial lung disease 16 6.0% 10 8
Cardiac failure 15 5.6% 3 5
Death 14 5.2% 14 1
Prostatic specific antigen increased 14 5.2% 9 5
Pleural effusion 10 3.7% 3 6
Disease progression 9 3.4% 5 2
Product use issue 9 3.4% 0 0
Anaemia 8 3.0% 5 2
Angioedema 8 3.0% 0 5
Constipation 8 3.0% 1 5
Osteonecrosis of jaw 8 3.0% 3 4
Thrombocytopenia 8 3.0% 0 2
Neutropenia 7 2.6% 1 1
Platelet count decreased 7 2.6% 0 6

Other Indications for ESTRAMUSTINE

Prostate cancer (105) Prostate cancer metastatic (29) Product used for unknown indication (23) Breast cancer metastatic (10) Neoplasm malignant (10) Metastases to bone (6)

Other Drugs Used for Hormone-refractory prostate cancer

ENZALUTAMIDE (8,881) RADIUM RA-223 DICHLORIDE (1,615) ABIRATERONE (1,378) DOCETAXEL (674) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579) DAROLUTAMIDE (553) CABAZITAXEL (524) PREDNISONE (474) APALUTAMIDE (365) OLAPARIB (313)

Related Pages

ESTRAMUSTINE Full Profile All Hormone-refractory prostate cancer Drugs ESTRAMUSTINE Demographics ESTRAMUSTINE Timeline